STAMBPL1 and plasma cell myeloma: reported that in multiple myeloma cells, AXL could regulate the expression of MICA (an immune response‐related gene) through the NF‐κB signaling pathway, implying a possible similar interaction in renal cancer.[69] A comprehensive analysis of the downstream targets of STAMBPL1 presents a challenging yet meaningful endeavor.